Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

New tool pinpoints genetic sources of disease

Many diseases are the result of either variations in the genome or reversible chemical changes to DNA, known as the epigenome. New data obtained by Johns Hopkins scientists show a connection between genetic variants and epigenetic information.

20 Mar 2014

Two new risk loci for bipolar disorder identified

Researchers have found two new risk loci for bipolar disorder in a genome-wide association study of 2.3 million single-nucleotide polymorphisms.

19 Mar 2014

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Using genomic analysis to study cancer in dogs can help develop new therapies for humans with cancer, according to a proof-of-concept study led by the National Cancer Institute (NCI) and the Translational Genomics Research Institute (TGen).

19 Mar 2014

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Porvair Sciences reports on positive commentary by researchers in published papers citing how using the fast, sensitive ChromaTrap™ Chromatin Immunoprecipitation (ChIP) technology has benefited their research.

From Chromatrap® - Porvair Sciences Ltd 18 Mar 2014

TAF proteins may serve as potential targets to fight ovarian cancer

In the complex genomic and molecular conspiracy that gives rise to ovarian cancer, what if researchers have been missing a whole set of suspects because they've been hiding in plain sight?

17 Mar 2014

Research may help develop senior-friendly exercise recommendations for improved physical function

Keeping strong and physically fit is crucial to maintaining independence among the elderly. Exercise has repeatedly been shown to reduce or slow age-related declines in physical function and is a widely recommended for seniors, but the way that older people respond to exercise varies widely.

17 Mar 2014

Findings reveal that miR-34 genes are bona fide tumor suppressors

Cornell University researchers report they have discovered direct genetic evidence that a family of genes, called MicroRNA-34 (miR-34), are bona fide tumor suppressors.

17 Mar 2014

Biomedical scientist to receive Chen Award for distinguished achievement in genetic and genomic research

The international Human Genome Organization (HUGO) will present its top award to Jackson Laboratory President and CEO Edison Liu, M.D.

17 Mar 2014

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Quintiles last night was named the "Best CRO in Asia" at the 2014 BioPharma Asia Industry Awards dinner, the third time in the event's four-year history that Quintiles has received the honor.

12 Mar 2014

Three innovative tools to detect, test and initiate personalized drug treatment for seizures

A team of researchers from the National Institutes of Health, Emory University and Cedars-Sinai - specialists in identifying and treating very rare diseases - used three innovative tools to detect a previously unknown gene mutation, test potential therapies in the lab, and initiate personalized drug treatment for a boy with a lifelong history of uncontrollable seizures that caused significant impact on his cognitive and social development.

12 Mar 2014

Researchers explore how genetics affects causes and prevalence of preterm birth

More than 450,000 babies are born too soon each year in the U.S. Preterm birth is a serious health problem that costs the nation more than $26 billion annually, according to the Institute of Medicine, and is the leading cause of newborn death.

12 Mar 2014

WuXi Genome Center buys Illumina HiSeq X Ten sequencing system

Illumina, Inc. and WuXi PharmaTech (Cayman) Inc., a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, today announced that the WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.

From Illumina, Inc. 10 Mar 2014

Dr. Daniel D. Von Hoff named one of ASCO's 50 Oncology Luminaries

In association with its 50th anniversary, the American Society of Clinical Oncology has named Dr. Daniel D. Von Hoff one of ASCO's 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care.

9 Mar 2014

STSI releases Scripps Wellderly Genome Resource to explore genetic cause for certain illness

Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool - a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI).

7 Mar 2014

TAZ gene represents potential target for drug therapies to treat aggressive types of breast cancer

Significance: Understanding more about how the different types of cells in breast tissue develop improves our knowledge of breast cancer. TAZ represents a potential new target for drug therapies to treat aggressive types of breast cancer.

7 Mar 2014

New drug is effective against superbug MRSA

"I routinely call hospitals and request their yearly antibiotic susceptibility testing data," said Washington University in St. Louis' Timothy Wencewicz. "The log might say, for example, that they've treated hundreds of patients for Acinetobacter baumanni, a bacterium brought into U.S. hospitals by soldiers wounded in the Iraq war, with 30 different antibiotics.

6 Mar 2014

Metabolon agrees to provide biochemical profiling services to Human Longevity

Metabolon, Inc., the world's leading commercial-stage metabolomics company, announces the signing of an agreement with newly-launched Human Longevity Inc., whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to tackle diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database.

5 Mar 2014

Human Longevity, UC San Diego sign new collaborative research agreement

The new collaborative research agreement between Human Longevity Inc. and the University of California, San Diego, announced today, represents a significant and necessary step in efforts to research and translate the potential of the human genome into novel and real treatments and therapies able to change and improve the human condition.

5 Mar 2014

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Researchers at the Translational Genomics Research Institute have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.

5 Mar 2014

Studies identify gene signals involved with BMI and their connection to: heart disease, diabetes

Two recent genetic studies expand the list of genes involved with body fat and body mass index, and their connection to major Western health problems: heart disease, high blood pressure and diabetes.

5 Mar 2014

Genomics News and Research

Further Reading

New tool pinpoints genetic sources of disease

Two new risk loci for bipolar disorder identified

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

TAF proteins may serve as potential targets to fight ovarian cancer

Research may help develop senior-friendly exercise recommendations for improved physical function

Findings reveal that miR-34 genes are bona fide tumor suppressors

Biomedical scientist to receive Chen Award for distinguished achievement in genetic and genomic research

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Three innovative tools to detect, test and initiate personalized drug treatment for seizures

Researchers explore how genetics affects causes and prevalence of preterm birth

WuXi Genome Center buys Illumina HiSeq X Ten sequencing system

Dr. Daniel D. Von Hoff named one of ASCO's 50 Oncology Luminaries

STSI releases Scripps Wellderly Genome Resource to explore genetic cause for certain illness

TAZ gene represents potential target for drug therapies to treat aggressive types of breast cancer

New drug is effective against superbug MRSA

Metabolon agrees to provide biochemical profiling services to Human Longevity

Human Longevity, UC San Diego sign new collaborative research agreement

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Studies identify gene signals involved with BMI and their connection to: heart disease, diabetes

Sequencing & Genomics: Elevating Science and Healthcare eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News